Dr. Atrayee Basu Mallick, MD

Dr. Basu Mallick practices at Jefferson Health Otolaryngology Head and Neck Surgery - HOPD in Philadelphia, Pennsylvania.

Dr. Basu Mallick's NPI, 1770802795, was assigned on June 1, 2010. Dr. Basu Mallick graduated from Medical College and Hospital Kolkata in 2000. Dr. Basu Mallick holds Pennsylvania license MD440064.

Dr. Basu Mallick's primary practice is Jefferson Health Otolaryngology Head and Neck Surgery - HOPD, at 925 Chestnut Street, Philadelphia, PA 19107.

Dr. Basu Mallick's primary practice is Jefferson Health Otolaryngology Head and Neck Surgery - HOPD in Philadelphia, Pennsylvania. Dr. Basu Mallick is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Basu Mallick to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basu Mallick practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Basu Mallick's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Basu Mallick is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Basu Mallick's licenses on file in 3 states: Pennsylvania, New Jersey and Delaware.

Dmand AI lists colorectal cancer among the conditions Dr. Basu Mallick treats.

CMS data shows 259 Medicare services from Dr. Basu Mallick across 5 procedure codes in 2024, for 104 Medicare patients. Medicare paid $16,506 for them.

CMS counts 104 Medicare patients who saw Dr. Basu Mallick in 2024. The largest group is 65 to 74, with 53 patients. 74% of them have high blood pressure, and 69% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basu Mallick's median patient age at 64, with 57% women.

In 2024, Dr. Basu Mallick wrote 133 Medicare Part D claims for 39 patients. 89% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $365 in total drug cost. In 2023, CMS named 115 claims across 6 drugs.

Dr. Basu Mallick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Basu Mallick as offering telehealth.

Dmand AI links 12 papers to Dr. Basu Mallick, published from 2019 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Adenocarcinoma, Pancreatic Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Basu Mallick has published most often in Am J Clin Pathol. Dr. Basu Mallick's most frequent co-authors are Babar Bashir, MD, Harish Lavu, MD and Charles J. Yeo, MD.

Dmand AI links Dr. Basu Mallick to 6 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Biliary Tract Neoplasms, Leiomyosarcoma and Lymphoma, B-Cell. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Basu Mallick that name 4 trials.

CMS Open Payments shows 83 general payments to Dr. Basu Mallick from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Deciphera Pharmaceuticals Inc. paid the most, $22,634. It also lists 16 research payments totaling $22,647 from 2018 to 2023, naming 4 clinical trials.

Dmand AI lists 4 awards for Dr. Basu Mallick, most recently CMS Stage 1 EHR in 2013.

Dr. Basu Mallick graduated from Medical College and Hospital Kolkata in 2000. Dr. Basu Mallick is a member of ASCO.

Dr. Basu Mallick is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.